New Jersey Courts Brace for Centralization of Ozempic and Wegovy NAION Lawsuits Amid Growing Concerns

Newark, New Jersey — A significant legal action is underway as plaintiffs seek to centralize lawsuits related to the diabetes medication Ozempic and the weight-loss drug Wegovy in New Jersey state court. This move comes amid growing concerns over the medications’ potential links to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION). The request for consolidation aims to streamline the legal proceedings, potentially allowing the cases to be handled more efficiently in a single jurisdiction. Legal representatives argue that unifying these complaints could save time and resources for both the courts … Read more

US Court Confirms FDA’s Decision to Ban Compounded Versions of Ozempic and Wegovy

A federal judge in New York has supported a U.S. Food and Drug Administration decision that prohibits the compounding of alternatives to the diabetes medication Ozempic and its weight-loss counterpart, Wegovy. The ruling comes amid soaring demand for these drugs, which have gained popularity for their effectiveness in managing weight. The case arose when a group of pharmacies sought to produce compounded versions of these medications, which are manufactured by Novo Nordisk. These compounded alternatives would allow pharmacists to create custom formulations for patients, yet the FDA argued that such practices may pose risks of … Read more

Weight Loss Drug Wegovy Linked to Serious Gallbladder Problems – Lawsuits Seek Compensation

CITY, STATE – National mass tort lawyers are currently investigating potential lawsuits related to the use of Wegovy, a prescription drug used for weight loss and weight management. Recent studies have revealed that the prolonged use of Wegovy may significantly increase the risk of developing gallbladder problems, such as gallbladder disease and gallstones. Until recently, the drug label for Wegovy did not contain any warning about the potential risk of gallbladder issues. As a result, product liability lawsuits have been filed, alleging that the drug maker negligently failed to provide adequate warnings. Individuals who have … Read more